ARVIND GULBAKE
VIDWAN ID: 271367

Dr ARVIND GULBAKE

Male Doctor of Philosophy
Assistant Professor | Department of Pharmaceutics
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH GUWAHATI
Assam
Expertise: Pharmacology and Pharmacy
74 Publications
0 Projects
1953 Scopus Citations
1753 CrossRef
5 Years 2 Months Total Experience
Publications
74 Total
Articles
63
Books
1
Chapters
10
Activity

No publication activity to display.

Scopus Scopus
1,953 Citations
22 h-index
CrossRef CrossRef
1,753 Citations
21 h-index
Google Scholar Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Personal Details

Doctor of Philosophy
2014
N/A
Assistant Professor
Jul 2021 – Present
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH GUWAHATI | Department of Pharmaceutics
Medical and Health Sciences
Pharmacology and Pharmacy

Related Profiles

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Mannosylated multiwalled carbon nanotubes assisted artesunate delivery for cerebral malaria

Open Access
Journal Article
International Journal of Applied Pharmaceutics. Year: 2019. Volume: 11 , Pages: 24-30 .
Authors: Anamika Sahu Gulbake; Aviral Jain; Satish Shilpi; Pramod Kumar; ARVIND GULBAKE

Solid tumors: A review

Review
Year: 2011. Volume: 3 , Issue: SUPPL. 5 , Pages: 45-51 .

A smart pH-responsive and sialic acid targeted hybrid nanoparticles for precise chemo-herbal delivery in lung cancer

Journal Article
Biomaterials Advances. Year: 2026. Volume: 185 .
Authors: Ankaj Kumar; Anurag Saini; Sourav Kundu; Pintu Das; Kalyan Kumar Sethi; Bidya Dhar Sahu; Arvind Gulbake

Xenobiotic-Induced Fetal Hepatocyte Maturation

Journal Article
Applied In Vitro Toxicology. Year: 2019. Volume: 5 , Issue: 4 , Pages: 180-186 .
Authors: Joshi, M.G.; Gulbake, A.; Kashte, S.B.; Borude, P.; Apte, U.; Sumitran-Holgersson, S.

Molecular Inclusion of ‘Brick Dust Molecule-Lenvatinib’ in Hydroxypropyl β-Cyclodextrin: Insights into Physicochemical, In Silico, and In Vitro Evaluations

Journal Article
Journal of Cluster Science. Year: 2026. Volume: 37 , Issue: 3 .
Authors: Nandkishor Rajankar; Ankaj Kumar; Saumya Ranjan Badajena; Purusottam Mohapatra; Arvind Gulbake

Augmenting Therapeutic Performance of CDK4/6 Inhibitor through a Nanocrystal-Integrated Thermoresponsive In Situ Gel Platform

Journal Article
Crystal Growth & Design. Year: 2026. Volume: 26 , Issue: 9 , Pages: 3670-3687 .
Authors: Vaibhav Dhumal; Bharath Manoharan; Rahul Nair; Mayur Aalhate; Srushti Mahajan; Priti Paul; Anish Dhuri; Tanmoy Kanp; Khushi Rode; Soumyadip Mukherjee; Arvind Gulbake; Pankaj Kumar Singh

Impact of Small Molecule Tyrosine Kinase Inhibitors Loaded Albumin-Based Nanoplatform on Triple Negative Breast Cancer Spheroid Model: an in Silico and in Vitro Study

Journal Article
BioNanoScience. Year: 2026. Volume: 16 , Issue: 3 .
Authors: Soumyadip Mukherjee; Ankaj Kumar; Rahul Kharat; Saurabh Jadhav; Vishal Kumar; Uday Kiran Roopavath; Arvind Gulbake

Exploring the potential of repurposed deferoxamine: bridging challenges and novel formulation opportunities

Review
Nanomedicine. Year: 2025. Volume: 20 , Issue: 16 , Pages: 2117-2141 .
Authors: Soumyadip Mukherjee; Akhila Reddy; Nikita Dutta; Klaudi K. Vaiphei; Vivek; Ankaj Kumar; Arvind Gulbake
Showing 1 to 8 of 74 publications